Topic: infectious disease
BiondVax secured a €20 million loan from the European Investment Bank to advance its universal flu vaccine candidate.
Florida lawmakers are urging the Army to pump the brakes on its exclusive vaccine license to Sanofi.
Scientists at the University of Maryland, hoping to fill the hepatitis vaccine void, have secured funding from the NIH to work on a new candidate.
The Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH are collaborating on a human trial of a novel malaria vaccine.
Bharat Biotech has initiated a phase 1 trial of its Chikungunya vaccine, while Themis started a phase 2 of its own candidate.
Bexsero has been helping drive revenue growth for GSK, but now, with an EU approval, Pfizer’s Trumenba is set to challenge it in that lucrative market.
Congolese officials have given initial approval to the use of Merck’s as-yet-unlicensed Ebola shot to combat a local outbreak.
The U.S. could run into a vaccine supply predicament if an influenza pandemic hits, since only one drugmaker has a domestic facility with egg-based vaccine production capabilities.
Health officials are in talks to deploy Merck & Co.’s experimental Ebola vaccine against a new outbreak in Congo.
The CDC is recommending PaxVax’s Vaxchora, the only FDA-approved cholera vaccine, for adults aged 18 to 64 traveling to areas where cholera is active.